share_log

Akero Therapeutics | 8-K: Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

SEC ·  Feb 29, 2024 20:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more